Company profile for Codiak BioSciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Using our engEx™ Platform, Codiak is developing a broad pipeline of product candidates that will have a transformative impact on the treatment of a broad spectrum of diseases with high unmet medical need. With an initial focus on immune cells, we are exploring the significant potential of this versatile and precise approach to engineering exosomes in the areas of oncology, immune-based diseases, metabolic and fibrotic disord...
Using our engEx™ Platform, Codiak is developing a broad pipeline of product candidates that will have a transformative impact on the treatment of a broad spectrum of diseases with high unmet medical need. With an initial focus on immune cells, we are exploring the significant potential of this versatile and precise approach to engineering exosomes in the areas of oncology, immune-based diseases, metabolic and fibrotic disorders, neurogenerative disorders and rare diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
500 Technology Square 9th Floor Cambridge, MA 02139
Telephone
Telephone
+1 (617) 949-4100
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Codiak Biosciences files for bankruptcy
Codiak Biosciences files for bankruptcy

27 Mar 2023

// James Waldron FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/codiak-biosciences-files-bankruptcy-after-unable-satisfy-financial-needs

James Waldron FIERCE BIOTECH
27 Mar 2023

https://www.globenewswire.com/news-release/2023/03/27/2634618/0/en/Codiak-BioSciences-to-Pursue-Asset-Sale-through-Voluntary-Chapter-11-Process.html

GLOBENEWSWIRE
27 Mar 2023

https://www.businesswire.com/news/home/20230124005425/en

BUSINESSWIRE
24 Jan 2023

https://www.globenewswire.com//news-release/2022/11/28/2563447/0/en/Codiak-BioSciences-to-Participate-5th-Annual-Evercore-ISI-HealthCONx-Conference.html

GLOBENEWSWIRE
28 Nov 2022

https://www.globenewswire.com/news-release/2022/11/03/2548229/0/en/Codiak-BioSciences-Reports-Third-Quarter-2022-Financial-Results-and-Operational-Progress.html

GLOBENEWSWIRE
03 Nov 2022

https://www.globenewswire.com/news-release/2022/10/12/2532827/0/en/Codiak-Presents-Preclinical-Data-Demonstrating-its-Pan-Beta-Coronavirus-Vaccine-Elicits-Broad-Protective-Immunity-Against-Known-Variants-of-SARS-CoV-2-and-Related-Sarbecoviruses.html

GLOBENEWSWIRE
12 Oct 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty